$6.33B Blackstone Biotech Fund: 86% Win-Rate Drug Roulette
TL;DR
* Blackstone closes $6.33B life sciences fund, largest ever, with $15B in assets under management and 86% approval rate for Phase III-backed drugs
* Rebellions raises $650M in six months, targets US market with RebelRack™ and RebelPOD™ HPC systems using UCIe and HBM3E
* ScaleOps raises $130M Series C at